🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you @Bahadır Güllüoğlu for the invite to join @Breastanbul 2024 lnkd.in/dsMUEhBu great sceintifc programme with outstanding faculty, exquisite planning and hospitality, great venue, and opportunity to catch up with friends and colleagues. Well done B.Güllüoğlu&team

Study Indicates Women Using #Levonorgestrel #IUDs Face Increased Risk Of #BreastCancerAwareness jamanetwork.com/journals/jama/…

Excited to share that I was granted promotion and tenure to Associate Professor in the college of Medicine at the University of Arkansas for Medical Sciences , thankful for all the support I received from mentors and colleagues #mmsm UAMS Myeloma Center

Join me today $:20 pm EST to discuss #global #equity in #clinical #trials @inaugral virtual event of #globalcancermovement initiated by ⁦OncoDaily⁩ ⁦ASCO⁩ ⁦ESMO - Eur. Oncology⁩ ⁦OncoAlert⁩ ⁦Nazik Hammad⁩ ascopubs.org/doi/full/10.12… linkedin.com/posts/oncodail…

Sana Al Sukhun solves the puzzle of equity of clinical trials piece by piece. Unique approach to a major issue🧩 Join us as we continue our insightful discussion during the Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer. Follow the link below:

Oral SERD @Imlunestrant in #EMBER3 is shifting the game! No need to check for ESR1 mutations when combined with @Verzenio, as revealed by Komal Jhaveri at SABCS. Insightful discussion by Harold J. Burstein, MD, PhD, FASCO! #BreastCancer #OncologyBreakthroughs nejm.org/doi/full/10.10…

@prat_aleix discusses promising #Asian data especially from Fudan University @ShanghaiCancerCentre with #antibody drug conjugate SHR-A1811 demonstrating non-inferiority to the standard quadruple therapy in early #BreastCancer #CancerResearch SABCS OncoDaily

Results from the @NRG Oncology/RTOG 9804 and @ECOG-ACRIN E5194 Trial for Good risk #DCIS INDEED reinforced the role of #RT to reduce local recurrence since Tam benefit was limited to ipsilat invasive recurrence rather than 5yrs of #Tamoxifen @SABCS OncoDaily

PATINA study of induction THP > maintenance HP + ET +/- palbo in ER+HER2+ MBC. Takeaway: after 6 cycles induction THP, patients can expect nearly 4 years of maintenance HP/ET/palbo on avg before re-needing chemo/ADC!

Thoughtful discussion of #ZEST trial & #ctDNA by Dr Krop in early #Breastcancer - bottom line “NOT IN CLINIC YET” SABCS #SABCS24 OncoDaily OncoAlert

Time to rethink who benefits from IO in Early TNBC, <10% benefit and >20% have long term AE- even the math does not add up #bcsm

Indeed, despite all the new hype and hope; chemo is still king

The American Society of Clinical Oncology issue a statement highlighted the link between alcohol and cancer in 2017. Now, the Surgeon General’s statement is a vital step to bring this issue to the forefront and raise public awareness. #alcoholandcancer ascopubs.org/doi/10.1200/JC…

JUST IN: Very important paper by the U.S. FDA about 2024 drug approvals published in Nature Reviews Drug Discovery by science writer extraordinaire Asher Mullard: Oncology drugs accounted for 30% of all novel approvals! nature.com/articles/d4157…

Had a great time @ #17thBGIICC, and #Oncothoracic int. congress Ontic; sharing ideas during my talk; connecting with so many brilliant colleagues. Huge thanks and congrats to Hesham ElGhazaly prof. Ola Khorshid and team for hosting such a fantastic event.#cancer #treatment #Oncology

Really enjoyed joining Emirates Oncology Society Best of SABCS and the interesting discussion. Congrats @Aydah_AlAwadhiand Prof.Dr.Humaid Al-Shamsi 🇦🇪 on excellent organization; great line of speakers; and great hospitality. SABCS #bcsm #brca ASCO

Yes, to smart biologic design; yes to logical neoadjuvant #immunotherapy approach ; yes to #de-#escalate and improve outcome; yes to reducing cost and subsequent expanded access #equity. #lungcancer OncoDaily ASCO

My father and role model has passed away. May his soul rest in eternal peace and his place be in the highest ranks of Jannah. You will live in our hearts and prayers forever.

Dual-payload ADCs are rising (fast!) 14 preclinical abstracts on dual payload ADCs at #AACR25 First dual payload ADC in the clinic by the end of April. China leads the way. From Lavinia Woodward (#Beacon)

Thrilled to have recommended such a talent - best wishes dear أ.د.أطلال أبوسند